Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir.
Hee-Jeong JeonSeok Won JungNeung-Hwa ParkYujin YangJin-Hee NohJae-Sung AhnHyung Rae KimJae Ho LeeJung Woo ShinPublished in: Clinical and molecular hepatology (2017)
TDF monotherapy was as effective as combination therapy of TDF+LAM or TDF+ETV in maintaining long-term viral suppression in chronic hepatitis B patients with resistance to both LAM and ETV. HBV DNA level at the start of TDF rescue therapy was the only independent predictor of subsequent VR.